(Q46684073)

24 December 2017

title

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension (English)

1 reference

24 December 2017

1 reference

1 reference

Mark R Lesk

1

1 reference

24 December 2017

Theodoro Koulis

2

1 reference

24 December 2017

Fotini Sampalis

3

1 reference

24 December 2017

John S Sampalis

4

1 reference

24 December 2017

Natacha R Bastien

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

25 March 2008

1 reference

24 December 2017

Annals of Pharmacotherapy

published in

1 reference

24 December 2017

volume

42

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

498-504

1 reference

24 December 2017

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

cites work

1 reference

Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma

21 January 2018

1 reference

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.

21 January 2018

1 reference

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

21 January 2018

1 reference

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

21 January 2018

1 reference

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

21 January 2018

1 reference

Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors

21 January 2018

1 reference

Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries.

21 January 2018

1 reference

The effects of antiglaucoma and systemic medications on ocular blood flow

21 January 2018

1 reference

21 January 2018

1 reference

Perspectives in the medical treatment of glaucoma

21 January 2018

1 reference

A comparison of the fixed combination of latanoprost and timolol with its individual components

21 January 2018

1 reference

A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

21 January 2018

1 reference

The efficacy and ocular discomfort of substituting brinzolamide for dorzolamide in combination therapy with latanoprost, timolol, and dorzolamide

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K565

1 reference

24 December 2017

1 reference

24 December 2017